Thursday, 9 December 2021

FDA clears AstraZeneca’s Covid antibody treatment for immunocompromised: Evusheld can be used as PrEP by people ages 12 & older who are moderately to severely immunocompromised and may not get adequate immune responses from a Covid vaccine.

FDA clears AstraZeneca’s Covid antibody treatment for immunocompromised: Evusheld can be used as PrEP by people ages 12 & older who are moderately to severely immunocompromised and may not get adequate immune responses from a Covid vaccine. submitted by /u/shallah
[link] [comments]


from Health https://ift.tt/3GsWjeP

No comments:

Post a Comment